Embryo Abortion: A Biological and Medical Explanation

Most embryonic losses happen because the embryo itself carries a fatal genetic error, not because something went wrong with the mother’s body. Roughly half of all first-trimester miscarriages trace back to chromosomal abnormalities in the embryo, making genetics the single largest driver of what clinicians call “spontaneous abortion.” But genetics is only one chapter in a much broader biological story. Hormones, immune signaling, uterine anatomy, the microbial communities lining the uterus, and even the father’s sperm quality all influence whether a pregnancy survives its earliest weeks.

Why Chromosomal Errors Are the Leading Cause

When a sperm and egg combine, each is supposed to contribute exactly 23 chromosomes. Errors during that process are strikingly common. In a study of 832 miscarriage samples, about 44% had chromosomal abnormalities, and the vast majority of those (over 84%) were aneuploidies, meaning the embryo had the wrong number of chromosomes. The most frequent single error was an extra copy of chromosome 16, followed by an extra chromosome 22 and the absence of one X chromosome. Parental age, especially the combined age of both parents, increased the risk of these errors.¹

Many embryos with severe chromosomal problems never make it far enough to be recognized as a pregnancy. Research on embryos created through IVF found that among those that stopped developing entirely in the lab, an extraordinary 94% were aneuploid, with errors often affecting multiple chromosomes at once.² These embryos essentially failed a built-in quality check. The body does not actively “reject” them in most cases; the embryo simply cannot sustain its own growth.

Mouse studies have helped clarify what happens at the cellular level when an embryo begins to fail. Research shows that spontaneous resorption starts with the embryo’s own cells undergoing programmed cell death (apoptosis) without any contribution from the mother’s immune system. Only after the embryo has already begun to break down does the mother’s body respond, sending immune cells called neutrophils to clear the tissue.³ This means the process is less like rejection and more like demolition of a structure that was already collapsing on its own.

Beyond Wrong Chromosome Counts

Not every genetic problem is as dramatic as a missing or extra chromosome. Smaller-scale errors, called copy number variations, involve segments of DNA that are duplicated or deleted. These can disrupt individual genes critical for embryonic development without changing the overall chromosome count. In one analysis of recurrent pregnancy loss, researchers identified duplications on specific sections of chromosomes 16 that appeared significantly more often in women who miscarried repeatedly compared to those who miscarried only once.⁴

A separate study cataloging gene disruptions found that among nearly a thousand protein-coding genes with known roles in mammalian development, 276 led to embryonic death or abnormal embryo and placenta formation when knocked out in mice.⁵ This gives a sense of how many genetic “weak points” exist during early development. A mutation in just one of these genes can be enough to derail the process even when the chromosome count looks completely normal.

Researchers examining 393 pregnancy loss cases found that while about half were chromosomally normal, over 52% of all cases showed some genetic abnormality when the analysis was expanded to include copy number variations and single gene mutations in addition to standard chromosome counts.⁶ The takeaway is that standard chromosome testing misses a meaningful fraction of genetic causes. As diagnostic tools improve, the proportion of “unexplained” miscarriages is shrinking.

The Hormonal Environment That Sustains or Fails a Pregnancy

Even a genetically healthy embryo cannot survive without the right hormonal support. Progesterone is the hormone most directly responsible for preparing the uterine lining and maintaining it during early pregnancy. A scoping review that examined 23 studies found that every single one reported a significant positive relationship between progesterone deficiency and first-trimester miscarriage, with the risk climbing further when low progesterone coincided with declines in other hormones.⁷

Progesterone’s role is not limited to a simple “high enough or not” question. The uterine lining itself has receptors for both estrogen and progesterone, and how those receptors are expressed matters. A study of women with a history of early miscarriage found that nearly two-thirds had abnormally elevated levels of both estrogen and progesterone receptors in their uterine lining, even though their blood hormone levels were perfectly normal. This overexpression appeared to reduce the lining’s ability to accept and nourish an embryo.⁸ In other words, having normal hormone levels in the bloodstream does not guarantee the uterus is responding to those hormones correctly.

Thyroid Function and Diabetes

Two metabolic conditions that fly under the radar deserve attention because they are common and treatable. Subclinical hypothyroidism, a mildly underactive thyroid that often produces no obvious symptoms, raises the risk of miscarriage. A systematic review and meta-analysis found that untreated subclinical hypothyroidism nearly doubled the risk of miscarriage compared to women with normal thyroid function. When thyroid autoimmunity (the immune system attacking the thyroid gland) was also present, the risk climbed even higher.⁹ The encouraging finding was that women who received thyroid treatment had no statistically significant increase in miscarriage risk compared to women with normal thyroid function, suggesting that screening and treatment could prevent some losses.

A prospective study drilling deeper into risk stratification found that when subclinical hypothyroidism and thyroid autoimmunity co-existed, the adjusted odds of miscarriage rose to more than nine times the baseline risk.¹⁰ This underscores why thyroid screening before or early in pregnancy has become increasingly common in clinical practice.

Diabetes follows a similar pattern. A meta-analysis found that diabetes overall was associated with a roughly 23% increased risk of miscarriage and a 73% increased risk of recurrent miscarriage. Type 2 diabetes carried a higher risk than Type 1, possibly reflecting associated metabolic disturbances like insulin resistance and obesity.¹¹ Both conditions are manageable, which makes their role in pregnancy loss especially frustrating when they go undiagnosed.

Immune Tolerance and Why the Body Does Not Usually Reject a Pregnancy

A pregnancy is an immunological paradox. The embryo carries genetic material from the father, making it partly “foreign” to the mother’s immune system. Under ordinary circumstances, the body attacks foreign tissue. Pregnancy succeeds because the uterine lining and the embryo negotiate a truce. Specialized cells from the embryo called trophoblasts invade the uterine lining and communicate directly with maternal immune cells, establishing a crosstalk that suppresses the usual immune attack.¹²

When this immune dialogue fails, the consequences can extend beyond miscarriage to conditions like pre-eclampsia and preterm birth. One condition that disrupts the dialogue is antiphospholipid syndrome, an autoimmune disorder in which antibodies trigger abnormal blood clotting. These antibodies activate blood vessel walls, immune cells, and platelets, creating a hypercoagulable state that can block blood flow to the placenta.¹³ Antiphospholipid syndrome is one of the few treatable autoimmune causes of recurrent miscarriage, typically managed with blood-thinning medication during pregnancy.

The Uterine Microbiome

The uterus was long thought to be sterile, but research over the past decade has shown it hosts a low-level community of bacteria. In a healthy state, these commensal bacteria appear to support immune balance by promoting the formation of regulatory T cells that help maintain tolerance toward the embryo. They also help maintain the integrity of the uterine lining’s surface.¹⁴

When this microbial community shifts toward a dysbiotic state, with fewer protective species and more pathogenic bacteria, the consequences cascade. The disrupted microbiome can reduce the production of antimicrobial peptides, weaken the barrier function of the uterine lining, and shift the immune response toward inflammation rather than tolerance.¹⁵ This is still an emerging field, and researchers have not yet established whether microbiome changes are a cause of pregnancy loss or merely a marker of other underlying problems. But the biological plausibility is strong enough that several clinical trials are now investigating whether restoring a healthy uterine microbiome can reduce miscarriage rates.

Uterine Shape and Structure

The uterus itself has to be built correctly for a pregnancy to have the best chance. Congenital uterine anomalies, structural differences present from birth, affect a meaningful fraction of women and can include a wall of tissue dividing the uterine cavity (septate uterus), a uterus shaped like a heart (bicornuate), or a uterus that developed from only one side (unicornuate). These anomalies are associated with recurrent pregnancy loss, preterm delivery, and a higher rate of cesarean sections.¹⁶

The mechanism appears to involve abnormal blood flow and reduced muscle mass in the uterine wall, which can limit the embryo’s ability to grow normally even after successful implantation.¹⁷ Interestingly, conditions not typically thought of as structural, like polycystic ovary syndrome, may also involve subtle uterine differences. A study comparing women with PCOS to matched controls found that those with PCOS had smaller overall uterine volume and a higher rate of uterine shape abnormalities, along with elevated miscarriage rates after embryo transfer.¹⁸

The Father’s Contribution to Embryonic Loss

Conversations about miscarriage tend to focus almost entirely on the mother, but the father’s biology matters too. Sperm carries half the embryo’s genetic material, and the integrity of that DNA influences what happens after fertilization. Sperm DNA fragmentation, measured by an index called DFI, reflects the degree of damage in the sperm’s genetic payload. In couples undergoing fertility treatment, those in the highest damage category (DFI above 30%) had significantly higher miscarriage rates than those with low damage levels, and this held true across different types of assisted reproduction.¹⁹

Beyond DNA damage, paternal genetic contributions to early embryonic arrest include chromosomal variations and mutations in specific genes involved in sperm development. Epigenetic modifications from the father, chemical tags on DNA that influence gene activity without changing the genetic code itself, also play a role in whether the embryo can successfully activate its own genome and begin developing independently.²⁰ This is an area where understanding has grown rapidly, driven largely by IVF research that allows embryos to be observed in ways that are impossible during natural conception.

How Medical Abortion Works Pharmacologically

While the sections above deal with spontaneous embryonic loss, it is worth understanding how medical abortion deliberately interrupts the same biological processes. The standard two-drug protocol targets the hormonal and mechanical foundations of early pregnancy.

Mifepristone, the first drug, works by binding to progesterone receptors with high affinity. When mifepristone occupies those receptors, it blocks progesterone from doing its job, effectively pulling the hormonal support out from under the pregnancy. Without progesterone’s activity, the uterine lining cannot maintain the embryo.²¹

Misoprostol, the second drug taken a day or two later, is a prostaglandin analogue that causes the cervix to soften and dilate while triggering uterine contractions. Its effects are dose-dependent and the route of administration matters; vaginal and buccal (held in the cheek) routes produce stronger uterine effects than swallowing the pill. In a large study of over 13,000 women using the mifepristone-misoprostol combination through 63 days of gestation, the overall efficacy was about 98%, with continuing pregnancy occurring in only 0.5% of cases. Rates of serious complications like infection requiring hospitalization or blood transfusion were each well under 1%.²²

Fertility After Pregnancy Loss

One of the most common questions after a miscarriage or early pregnancy termination is how long to wait before trying again. Older guidelines often recommended waiting three to six months, but the evidence does not support that advice. A study tracking women after early pregnancy loss found that those who started trying within three months were actually more likely to become pregnant (about 69% versus 51%) and more likely to have that pregnancy result in a live birth (about 53% versus 36%) compared to women who waited longer. There was no increased risk of complications like another miscarriage, preterm birth, or preeclampsia in the group that tried sooner.²³

For women wondering whether the type of treatment for miscarriage matters for future fertility, a study comparing medical management (using medications to complete the miscarriage) versus surgical evacuation found that conception rates six months later were essentially identical, at 68% and 65% respectively, with median time to conception of about four months in both groups.²⁴ The method used to manage the loss does not appear to affect your ability to conceive afterward.

What IVF Has Revealed About Early Embryonic Failure

In vitro fertilization has become an unintentional window into a process that is normally invisible. During natural conception, embryos that fail in the first few days are lost before a woman even knows she was pregnant, often before a period is missed. IVF laboratories observe this process directly, and what they see is sobering.

Systematic reviews of IVF embryos that stop developing have identified a web of interacting factors: gene variations in both the embryo and the parents, abnormal mitochondrial DNA copy numbers, disrupted methylation patterns (the chemical marks that control which genes are turned on or off), metabolic differences, and visible structural abnormalities in the embryo itself. Parental factors like specific protein expression levels and the underlying cause of their infertility also contribute to whether embryos arrest.²⁵

A critical event in early development is embryonic genome activation, the moment when the embryo’s own genes take over from the initial instructions provided by the egg. This transition happens around the third day after fertilization in humans. Disruptions to key genes involved in this activation, alongside problems with mitochondrial function and small regulatory RNA molecules, are increasingly recognized as major contributors to the earliest failures.²⁰ Much of what we now understand about why embryos fail before implantation comes from IVF research, and those insights are gradually reshaping how clinicians think about natural conception losses as well.

How Early Pregnancy Loss Is Diagnosed

The clinical tools for distinguishing a healthy early pregnancy from one that has failed are ultrasound and blood testing for hCG (human chorionic gonadotropin, the hormone that pregnancy tests detect). Transvaginal ultrasound, introduced over three decades ago, remains the standard method. But diagnosing a failed pregnancy requires conservative, standardized criteria to avoid the catastrophic error of misidentifying a viable pregnancy as a loss. Guidelines call for specific measurements, like a minimum embryo size without a heartbeat, or a minimum gestational sac size without a visible embryo, before a diagnosis of pregnancy failure can be made.²⁶ When there is any ambiguity, clinicians repeat the ultrasound after a waiting period rather than act on a single scan. The emotional toll of that waiting period is real, but the alternative, acting on an uncertain diagnosis, is worse.

Veterinary Parallels

The biological processes described above are not unique to humans. Embryonic loss occurs across mammalian species and is managed medically in veterinary practice as well. In dogs and cats, for example, pharmacologic approaches to pregnancy termination use some of the same biological principles: progesterone antagonists and prostaglandin analogues are employed, though the specific drugs, dosing, and safety profiles differ substantially from human protocols. Newer agents have been developed to improve efficacy and reduce side effects in companion animals, reflecting the same pharmaceutical trajectory seen in human reproductive medicine.²⁷ The shared biology between species is part of why animal models, particularly mouse studies on embryonic resorption, have been so useful in understanding the mechanisms of human pregnancy loss.